118 related articles for article (PubMed ID: 8804553)
1. Comparison of tacrine-induced cytotoxicity in primary cultures of rat, mouse, monkey, dog, rabbit, and human hepatocytes.
Monteith DK; Theiss JC
Drug Chem Toxicol; 1996; 19(1-2):59-70. PubMed ID: 8804553
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxicity study of tacrine, structurally and pharmacologically related compounds using rat hepatocytes.
Monteith DK; Emmerling MR; Garvin J; Theiss JC
Drug Chem Toxicol; 1996; 19(1-2):71-84. PubMed ID: 8804554
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxicity of tacrine and velnacrine metabolites in cultured rat, dog and human hepatocytes.
Viau CJ; Curren RD; Wallace K
Drug Chem Toxicol; 1993; 16(3):227-39. PubMed ID: 8404544
[TBL] [Abstract][Full Text] [Related]
4. Toxic effects of tacrine on primary hepatocytes and liver epithelial cells in culture.
Lagadic-Gossmann D; Rissel M; Le Bot MA; Guillouzo A
Cell Biol Toxicol; 1998 Oct; 14(5):361-73. PubMed ID: 9808364
[TBL] [Abstract][Full Text] [Related]
5. Metabolism and cytotoxicity of acetaminophen in hepatocyte cultures from rat, rabbit, dog, and monkey.
Smolarek TA; Higgins CV; Amacher DE
Drug Metab Dispos; 1990; 18(5):659-63. PubMed ID: 1981716
[TBL] [Abstract][Full Text] [Related]
6. Acute effects of huperzine A and tacrine on rat liver.
Ma XC; Xin J; Wang HX; Zhang T; Tu ZH
Acta Pharmacol Sin; 2003 Mar; 24(3):247-50. PubMed ID: 12617774
[TBL] [Abstract][Full Text] [Related]
7. Functional and subcellular organelle changes in isolated rat and human hepatocytes induced by tetrahydroaminoacridine.
Monteith DK; Theiss JC; Haskins JR; de la Iglesia FA
Arch Toxicol; 1998 Feb; 72(3):147-56. PubMed ID: 9520138
[TBL] [Abstract][Full Text] [Related]
8. In vitro toxicity of zamifenacin (UK-76,654) and metabolites in primary hepatocyte cultures.
Amacher DE; Fasulo LM; Charuel C; Comby P; Beaumont K
Xenobiotica; 1998 Sep; 28(9):895-908. PubMed ID: 9764931
[TBL] [Abstract][Full Text] [Related]
9. Tacrine treatment at high dose suppresses the recognition memory in juvenile and adult mice with attention to hepatotoxicity.
Pan SY; Guo BF; Zhang Y; Yu Q; Yu ZL; Dong H; Ye Y; Han YF; Ko KM
Basic Clin Pharmacol Toxicol; 2011 Jun; 108(6):421-7. PubMed ID: 21232021
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the cytotoxicity of sodium valproate on primary cultured rat hepatocytes.
Takeuchi T; Sugimoto T; Nishida N; Kobayashi Y
Neuropediatrics; 1988 Aug; 19(3):158-61. PubMed ID: 3146709
[TBL] [Abstract][Full Text] [Related]
11. Genotoxicity of tacrine in primary hepatocytes isolated from B6C3F1 mice and aged ad libitum and calorie restricted Fischer 344 rats.
Shaddock JG; Feuers RJ; Chou MW; Swenson DH; Casciano DA
Mutat Res; 1995 Aug; 344(1-2):79-88. PubMed ID: 7565897
[TBL] [Abstract][Full Text] [Related]
12. Effect of glutathione depletion and oxidative stress on the in vitro cytotoxicity of velnacrine maleate.
al Casey S; Brewster D; Viau C; Acosta D
Toxicol Lett; 1995 Apr; 76(3):257-65. PubMed ID: 7762013
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxicity of 34 FDA approved small-molecule kinase inhibitors in primary rat and human hepatocytes.
Zhang J; Ren L; Yang X; White M; Greenhaw J; Harris T; Wu Q; Bryant M; Papoian T; Mattes W; Shi Q
Toxicol Lett; 2018 Jul; 291():138-148. PubMed ID: 29655783
[TBL] [Abstract][Full Text] [Related]
14. Metabolism and cytotoxicity of acetaminophen in hepatocytes isolated from resistant and susceptible species.
Green CE; Dabbs JE; Tyson CA
Toxicol Appl Pharmacol; 1984 Oct; 76(1):139-49. PubMed ID: 6484984
[TBL] [Abstract][Full Text] [Related]
15. Cytoprotective constituent of Hoveniae Lignum on both Hep G2 cells and rat primary hepatocytes.
An RB; Park EJ; Jeong GS; Sohn DH; Kim YC
Arch Pharm Res; 2007 Jun; 30(6):674-7. PubMed ID: 17679542
[TBL] [Abstract][Full Text] [Related]
16. Metabolism and toxicity of coumarin on cultured human, rat, mouse and rabbit hepatocytes.
Ratanasavanh D; Lamiable D; Biour M; Guédès Y; Gersberg M; Leutenegger E; Riché C
Fundam Clin Pharmacol; 1996; 10(6):504-10. PubMed ID: 8985719
[TBL] [Abstract][Full Text] [Related]
17. Tacrine, an oral acetylcholinesterase inhibitor, induced hepatic oxidative damage, which was blocked by liquiritigenin through GSK3-beta inhibition.
Park SM; Ki SH; Han NR; Cho IJ; Ku SK; Kim SC; Zhao RJ; Kim YW
Biol Pharm Bull; 2015; 38(2):184-92. PubMed ID: 25747977
[TBL] [Abstract][Full Text] [Related]
18. Hepatotoxicity of tacrine: occurrence of membrane fluidity alterations without involvement of lipid peroxidation.
Galisteo M; Rissel M; Sergent O; Chevanne M; Cillard J; Guillouzo A; Lagadic-Gossmann D
J Pharmacol Exp Ther; 2000 Jul; 294(1):160-7. PubMed ID: 10871308
[TBL] [Abstract][Full Text] [Related]
19. Tacrine-NO donor and tacrine-ferulic acid hybrid molecules as new anti-Alzheimer agents: hepatotoxicity and influence on the cytochrome P450 system in comparison to tacrine.
Lupp A; Appenroth D; Fang L; Decker M; Lehmann J; Fleck C
Arzneimittelforschung; 2010; 60(5):229-37. PubMed ID: 20533758
[TBL] [Abstract][Full Text] [Related]
20. Elucidation of mitochondrial effects by tetrahydroaminoacridine (tacrine) in rat, dog, monkey and human hepatic parenchymal cells.
Robertson DG; Braden TK; Urda ER; Lalwani ND; de la Iglesia FA
Arch Toxicol; 1998 May; 72(6):362-71. PubMed ID: 9657284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
